At the Bloom Burton & Co Healthcare Investor Conference this May, Knight Therapeutics’ president, Samira Sakhia (BCom’90, DPA’94, MBA’01) will be giving the Montreal-based specialty...
“I’m not looking at fashion through a Canadian lens, or even a Western lens, but a global lens,” says Imran Amed (BCom'97). Indeed, he doesn’t even look at it through the eyes of someone who grew...
Aldo Bensadoun (BCom'64, LLD'12) is stepping down as chairman of the company that bears his name, as is CEO Patrik Frisk — but continuity won’t be a problem: Bensadoun’s son, David, is taking on...
In its 2016 financial results press release, Mississauga-based Profound Medical announced the appointment of Samira Sakhia (BCom’90, MBA’01) to its Board of Directors. Ms. Sakhia is also a member...
Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. ("Paladin"), will be joining...
This op-ed was written by Mr. Ron Duerksen, chief strategy officer at the Desautels Faculty of Management, in partnership with leading business people and Desautels grads, listed at bottom.
Samira Sakhia, president of Knight Therapeutics, has joined Crescita Therapeutics Inc.’s board of directors. Prior to her current role, she was the chief financial officer of Paladin Labs. She...
Nuvo Research Inc. (TSX:NRI) (Nuvo or the Company), a specialty pharmaceutical company with growing revenues and a diverse portfolio of topical and immunology products, today announced the...
RSS